BlackRock’s LYRA THERAPEUTICS INC LYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-2,394
| Closed | -$7.37K | – | 5754 |
|
|
2025
Q4 | $7.37K | Buy |
2,394
+704
| +42% | +$3.5K | ﹤0.01% | 5309 |
|
|
2025
Q3 | $11K | Hold |
1,690
| – | – | ﹤0.01% | 5205 |
|
|
2025
Q2 | $15.1K | Sell |
1,690
-58,690
| -97% | -$487K | ﹤0.01% | 5174 |
|
|
2025
Q1 | $381K | Sell |
60,380
-1,816
| -3% | -$17K | ﹤0.01% | 4465 |
|
|
2024
Q4 | $642K | Buy |
62,196
+2,323
| +4% | +$25.6K | ﹤0.01% | 4348 |
|
|
2024
Q3 | $769K | Buy |
59,873
+3,273
| +6% | +$48.1K | ﹤0.01% | 4233 |
|
|
2024
Q2 | $783K | Buy |
56,600
+53,562
| +1,763% | +$6.06M | ﹤0.01% | 4238 |
|
|
2024
Q1 | $945K | Buy |
3,038
+822
| +37% | +$219K | ﹤0.01% | 4211 |
|
|
2023
Q4 | $581K | Buy |
2,216
+1,266
| +133% | +$229K | ﹤0.01% | 4392 |
|
|
2023
Q3 | $186K | Sell |
950
-22
| -2% | -$3.94K | ﹤0.01% | 4700 |
|
|
2023
Q2 | $200K | Buy |
972
+144
| +17% | +$20K | ﹤0.01% | 4734 |
|
|
2023
Q1 | $83.2K | Buy |
828
+26
| +3% | +$3.22K | ﹤0.01% | 5001 |
|
|
2022
Q4 | $126K | Buy |
802
+22
| +3% | +$4.36K | ﹤0.01% | 4972 |
|
|
2022
Q3 | $196K | Sell |
780
-52
| -6% | -$15.4K | ﹤0.01% | 4981 |
|
|
2022
Q2 | $235K | Buy |
832
+452
| +119% | +$123K | ﹤0.01% | 4995 |
|
|
2022
Q1 | $77K | Buy |
380
+15
| +4% | +$3.29K | ﹤0.01% | 5341 |
|
|
2021
Q4 | $80K | Buy |
365
+9
| +3% | +$2.89K | ﹤0.01% | 5324 |
|
|
2021
Q3 | $163K | Sell |
356
-46
| -11% | -$17.4K | ﹤0.01% | 5028 |
|
|
2021
Q2 | $161K | Sell |
402
-6,566
| -94% | -$2.99M | ﹤0.01% | 4944 |
|
|
2021
Q1 | $4.04M | Buy |
6,968
+1,685
| +32% | +$1.05M | ﹤0.01% | 4035 |
|
|
2020
Q4 | $3.01M | Buy |
5,283
+1,136
| +27% | +$640K | ﹤0.01% | 3897 |
|
|
2020
Q3 | $2.32M | Buy |
4,147
+42
| +1% | +$26.1K | ﹤0.01% | 3862 |
|
|
2020
Q2 | $2.33M | Buy |
+4,105
| New | +$3M | ﹤0.01% | 3781 |
|
Other funds holding LYRA
BlackRock's LYRA Position: Q1 2026 in Review
BlackRock sold out of LYRA THERAPEUTICS INC (LYRA) in Q1 2026, closing a stake of 2,394 shares — an estimated $7.37K sold.
BlackRock first reported a position in LYRA in Q2 2020 and held it in 23 quarters. The position peaked at $4.04M in Q1 2021. 1 fund tracked by Wall St. Rank holds LYRA as of Q1 2026.
- BlackRock reported no remaining LYRA THERAPEUTICS INC position as of Q1 2026 after selling out during the quarter.
- BlackRock sold 2,394 LYRA THERAPEUTICS INC shares in Q1 2026, an estimated $7.37K.
- BlackRock first reported a position in LYRA THERAPEUTICS INC in Q2 2020 and held it in 23 quarters.
- BlackRock's LYRA THERAPEUTICS INC position peaked at $4.04M in Q1 2021.
- 1 fund tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q1 2026.
Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.